Chemotherapy for breast cancer.
D000328:Adult; D000477:Alkylating Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D009316:National Institutes of Health (U.S.); D011241:Prednisone / Q000008:administration & dosage; D011956:Receptors, Cell Surface; D014481:United States
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D011956:Receptors, Cell Surface; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate